PolyPeptide Group AG (XSWX:PPGN) ROE % Adjusted to Book Value : -5.48% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is PolyPeptide Group AG ROE % Adjusted to Book Value?

PolyPeptide Group AG's ROE % for the quarter that ended in Dec. 2023 was -8.82%. PolyPeptide Group AG's PB Ratio for the quarter that ended in Dec. 2023 was 1.61. PolyPeptide Group AG's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was -5.48%.

PolyPeptide Group AG ROE % Adjusted to Book Value Historical Data

The historical data trend for PolyPeptide Group AG's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PolyPeptide Group AG ROE % Adjusted to Book Value Chart

PolyPeptide Group AG Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

1.51

0.90

-7.77

PolyPeptide Group AG Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial					1.06	0.98	-0.58	-10.24	-5.48

Competitive Comparison of PolyPeptide Group AG's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, PolyPeptide Group AG's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PolyPeptide Group AG's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PolyPeptide Group AG's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where PolyPeptide Group AG's ROE % Adjusted to Book Value falls into.

PolyPeptide Group AG ROE % Adjusted to Book Value Calculation

PolyPeptide Group AG's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-12.51%	/	1.61
	=	-7.77%

PolyPeptide Group AG's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-8.82%	/	1.61
	=	-5.48%

PolyPeptide Group AG ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of PolyPeptide Group AG's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

PolyPeptide Group AG (XSWX:PPGN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PolyPeptide Group AG (XSWX:PPGN) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

PPGNz:UK

Address

Neuhofstrasse 24, Baar, Zug, CHE, 6340

Website

https://www.polypeptide.com

PolyPeptide Group AG is an independent contract development and manufacturing organization (CDMO) focused on peptides and oligonucleotides employed as an active pharmaceutical ingredients (APIs) and used as intermediates in therapeutic products. The company derives a majority of its revenue from Europe and Asia.

PolyPeptide Group AG (XSWX:PPGN) Headlines

No Headlines